White House Announces New Deals with Pharmaceutical Manufacturers to Lower Drug Prices

President Donald J. Trump announced nine new agreements with pharmaceutical manufacturers to lower prescription drug prices for Americans through Most-Favored-Nation (MFN) pricing. These agreements, which bring the total number of manufacturers with MFN deals to 26, aim to provide State Medicaid programs access to lower drug prices and ensure foreign nations cannot freeride on American innovation. The initiative is expected to result in billions of dollars in savings.